Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D01NAM
|
|||
Former ID |
DCL001108
|
|||
Drug Name |
ELB-139
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Anxiety disorder [ICD-11: 6B00-6B0Z; ICD-10: R45.0] | Discontinued in Phase 2 | [1] | |
Therapeutic Class |
Psychiatric
|
|||
Company |
Elbion AG; 4AZA Bioscience
|
|||
Structure |
Download2D MOL |
|||
Formula |
C14H16ClN3O
|
|||
Canonical SMILES |
C1CCN(CC1)C2=NC(=O)N(C2)C3=CC=C(C=C3)Cl
|
|||
InChI |
1S/C14H16ClN3O/c15-11-4-6-12(7-5-11)18-10-13(16-14(18)19)17-8-2-1-3-9-17/h4-7H,1-3,8-10H2
|
|||
InChIKey |
YGXIELIREXEJQN-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 188116-08-7
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Glutamate receptor AMPA (GRIA) | Target Info | Modulator | [2] |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800020261) | |||
REF 2 | Glutamate- and GABA-based CNS therapeutics. Curr Opin Pharmacol. 2006 Feb;6(1):7-17. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.